Showing 1 - 20 results of 139 for search '"АВТОНОМНАЯ НЕРВНАЯ СИСТЕМА"', query time: 0.81s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
    Academic Journal

    File Description: application/pdf

    Relation: Ткаченко Е. В. Взаимосвязь между показателями автономной регуляции, особенностями МПА и успеваемостью иностранных студенток из Ирана, Марокко и Туниса / Е. В. Ткаченко // Наукові тренди постіндустріального суспільства : матеріали II Міжнар. наук. конф., м. Запоріжжя, 3 грудня 2021 р. / Міжнародний центр наукових досліджень. – Вінниця : Європейська наукова платформа, 2021. – Т. 3. – С. 14–16.; https://repository.pdmu.edu.ua/handle/123456789/17251

  13. 13
  14. 14
    Academic Journal

    Source: General Reanimatology; Том 17, № 1 (2021); 16-26 ; Общая реаниматология; Том 17, № 1 (2021); 16-26 ; 2411-7110 ; 1813-9779

    File Description: application/pdf

    Relation: https://www.reanimatology.com/rmt/article/view/2011/1476; https://www.reanimatology.com/rmt/article/view/2011/1483; Mahmoud M., Mason K.P. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. BJA: British Journal of Anaesthesia, 2015; 115 (2): 171–182. DOI:10.1093/bja/aev226.; Sharp D.B., Wang X., Mendelowitz D. Dexmedetomidine decreases inhibitory but not excitatory neurotransmission to cardiac vagal neurons in the nucleus ambiguus. Brain Res. 2014; 1574: 1–5. DOI:10.1016/j.brainres.2014.06.010. PMID 24933328.; Aikaterini A., Ioannis D., Dimitrios G., Konstantinos S., Vasilios G., George P. Bradycardia Leading to Asystole Following Dexmedetomidine Infusion during Cataract Surgery: Dexmedetomidine-Induced Asystole for Cataract Surgery. Case Rep Anesthesiol. 2018; 2018: 2896032. DOI:10.1155/2018/2896032. PMID: 30627445.; Jin S., Zhou X. Influence of dexmedetomidine on cardiac complications in non-cardiac surgery: a meta-analysis of randomized trials. Int J Clin Pharm. 2017; 39 (4): 629–640. DOI:10.1007/s11096-017-0493-8. PMID: 2866046.; Mahmoud M., Mason K.P. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. BJA: British Journal of Anaesthesia. 2015: 115 (2): 171–182. DOI:10.1093/bja/aev226]; Peng Y., Haifeng Z., Haodong C., Zijin Z., Huahai Z., Shuguang Z., Lili G., Lei S., Xiaoliang L., Zhengxiang L. Dexmedetomidine attenuates acute paroxysmal sympathetic hyperactivity. Oncotarget. 2017; 8 (40): 69012–69019. DOI:10.18632/oncotarget.16920 PMCD5620316.; Кирячков Ю.Ю., Салтанов А.И., Хмелевский Я.М. Компьютерный анализ вариабельности ритма сердца. Новые возможности для анестезиолога и врачей других специальностей. Вестник интенсивной терапии. 2002 1: 3–8.; Esterov D., Greenwald B.D. Autonomic dysfunction after mild traumatic brain injury. Brain Sci. 2017; 11; 7 (8). DOI:10.3390/brainsci7080100. PMID: 28800081.; Meyfroidt G., Baguley I.J., Menon D.K. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol. 2017; 16 (9): 721–729. DOI:10.1016/S1474-4422(17)30259-4. PMID 28816118.; Godo S., Irino S., Nakagawa A., Kawazoe Y., Fujita M., Kudo D., Nomura R., Shimokawa H., Kushimoto S. Diagnosis and Management of Patients with Paroxysmal Sympathetic Hyperactivity following Acute Brain Injuries Using a Consensus-Based Diagnostic Tool: A Single Institutional Case Series. Tohoku J Exp Med. 2017; 243 (1): 11–18. DOI:10.1620/tjem.243.11. PMID 28890524.; Jiang L., Hu M., Lu Y., Cao Y., Chang Y., Dai Z. The protective effects of dexmedetomidine on ischemic brain injury: A meta-analysis. J Clin Anesth. 2017; 40: 25–32. DOI:10.1016/j.jclinane.2017.04.003. PMID 28625441.; Yamanaka D., Kawano T., Nishigaki A., Aoyama B., Tateiwa H., Shigematsu-Locatelli M., Locatelli F.M., Yokoyama M. Preventive effects of dexmedetomidine on the development of cognitive dysfunction following systemic inflammation in aged rats. J Anesth. 2017; 31 (1): 25– 35. DOI:10.1007/s00540-016-2264-4. PMID 27738803.; Kanashiro A., Sônego F., Ferreira R.G., Castanheira F.V.,Leite C.A., Borges V.F., Nascimento D.C., Cólon D.F.,Alves-Filho J.C., Ulloa L., Cunha F.Q. Therapeutic potential and limitations of cholinergic antiinflammatory pathway in sepsis. Pharmacol Res. 2017; 117: 1–8. DOI:10.1016/j.phrs.2016.12.014. PMID 27979692.; Samuel S., Allison T.A., Lee K., Choi H.A. Pharmacologic management of paroxysmal sympathetic hyperactivity after brain injury. J. Neurosci. Nurs. 2016; 48 (2): 82–89. DOI:10.1097/JNN.0000000000000207. PMID: 26954919.; Wang X., Ji J., Fen L., Wang A. Effects of dexmedetomidine on cerebral blood flow in critically ill patients with or without traumatic brain injury: a prospective controlled trial. Brain Inj. 2013; 27 (13–14): 1617– 1622. DOI:10.3109/02699052.2013.831130. PMID 24102571.; Ding X.D., Zheng N.N., Cao Y.Y., Zhao G.Y., Zhao P. Dexmedetomidine preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest. Int J Neurosci. 2016; 126 (3): 249–256. DOI:10.3109/00207454.2015.1005291. PMID 25565380.; Wu G.J., Chen J.T., Tsai H.C., Chen T.L., Liu S.H., Chen R.M. Protection of Dexmedetomidine Against Ischemia/Reperfusion-Induced Apoptotic Insults to Neuronal Cells Occurs Via an Intrinsic MitochondriaDependent Pathway. J Cell Biochem. 2017; 118 (9): 2635–2644. DOI:10.1002/jcb.25847. PMID 27987330.; Endesfelder S., Makki H., von Haefen C., Spies C.D., Bührer C., Sifringer M. Neuroprotective effects of dexmedetomidine against hyperoxiainduced injury in the developing rat brain. PLoS One. 2017; 12 (2): e0171498. DOI:10.1371/journal.pone.0171498. PMID 28158247.; Akpýnar O., Nazýroðlu M., Akpýnar. Different doses of dexmedetomidine reduce plasma cytokine production, brain oxidative injury, PARP and caspase expression levels but increase liver oxidative toxicity in cerebral ischemia-induced rats. Brain Res Bull. 2017; 130: 1– 9. DOI:10.1016/j.brainresbull.2016.12.005. PMID 28007581.; Xu K.L., Liu X.Q., Yao Y.L., Ye M.R., Han Y.G., Zhang T.,Chen G., Lei M. Effect of dexmedetomidine on rats with convulsive status epilepticus and association with activation of cholinergic anti-inflammatory pathway. Biochem Biophys Res Commun. 2018; 495 (1): 421–426. DOI:10.1016/j.bbrc.2017.10.124. PMID 29080744.; Shin S., Lee J.W., Kim S.H., Jung Y.S., Oh Y.J. Heart rate variability dynamics during controlled hypotension with nicardipine, remifentanil and dexmedetomidine. Acta Anaesthesiol Scand. 2014; 58 (2): 168– 176. DOI:10.1111/aas.12233. PMID 24261345.; Cho J.S., Kim S.H., Shin S., Pak H.N., Yang S.J., Oh Y.J. Effects of Dexmedetomidine on Changes in Heart Rate Variability and Hemodynamics During Tracheal Intubation. Am J Ther. 2016; 23 (2): e369- 76. DOI:10.1097/MJT.0000000000000074. PMID 24832388.; Kim M.H., Lee K.Y., Bae S.J., Jo M., Cho J. Intraoperative dexmedetomidine attenuates stress responses in patients undergoing major spine surgery. Minerva Anestesiol. 2019; 85 (5): 468–477. DOI:10.23736/S0375-9393.18.12992-0. PMID: 30226342.; https://www.reanimatology.com/rmt/article/view/2011

  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
    Academic Journal

    Contributors: ФГБУ "НМИЦ им. В.А. Алмазова" МЗ РФ

    Source: Translational Medicine; Том 6, № 3 (2019); 5-14 ; Трансляционная медицина; Том 6, № 3 (2019); 5-14 ; 2410-5155 ; 2311-4495 ; 10.18705/2311-4495-2019-6-3

    File Description: application/pdf

    Relation: https://transmed.almazovcentre.ru/jour/article/view/473/338; Трешкур Т. В., Тулинцева Т. Э., Татаринова А. А. и др. Желудочковые аритмии и холтеровское мониторирование — принципы формирования заключения по результатам исследования. Вестник аритмологии. 2018;93:53–63.; Лупанов В. П., Нуралиев Э. Ю., Сергиенко И. В. Функциональные нагрузочные пробы в диагностике ишемической болезни сердца, оценке риска осложнений и прогноза. М.: ПатиСС, 2016. с. 309.; Drew BJ, Califf RM, Funk M et al. Practice Standards for Electrocardiographic Monitoring in Hospital Settings: an American Heart Association Scientifi c Statement from the Councils on Cardiovascular Nursing, Clinical Cardiology, and Cardiovascular Disease in the Young: Endorsed by the International Society of Computerized Electrocardiology and the American Association of Critical-Care Nurses. Circulation. 2004; 110 (17): 2721–2746.; Brignole M, Moya A, de Lange FJ et al. 2018 ESC Guidelines for the Diagnosis and Management of Syncope. Eur Heart J. 2018; 39 (21): 1883–1948.; Issa ZF, Miller JM, Zipes DP. Clinical Arrhythmology and Electrophysiology: a Companion to Braunwald's Heart Disease. Elsevier Inc. 2009. p. 520; Brignole M, Auricchio A, Baron-Esquivias G et al. 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy: the Task Force on Cardiac Pacing and Resynchronization Therapy of the European Society of Cardiology (ESC). Developed in Collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013; 34 (29): 2281–2329.; Трешкур Т. В., Бернгардт Э. Р., Тихоненко В. М. Атриовентрикулярные блокады: этиология, клиника, диагностика, лечение: Учебное пособие. 2-е изд. М.: Издательство МИА, 2018. с. 168.; Kusumoto FM, Schoenfeld MH, Barrett C, 2018 ACC/ AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. J Am Coll Cardiol. 2018. pii: S0735–1097 (18) 38984–8.; Woelfel AK, Simpson RJ Jr, Gettes LS et al. ExerciseInduced Distal Atrioventricular Block. J Am Coll Cardiol. 1983; 2 (3): 578–581.; Issa ZF, Miller JM, Zipes DP. Atrioventricular Conduction Abnormalities. In: Clinical Arrhythmology and Electrophysiology: A Companion to Braunwald's Heart Disease. 2nd ed. Elseiver Inc. 2012: 175–193.; Bakst A, Goldberg B, Schamroth L. Signifi cance of Exercise-Induced Second Degree Atrioventricular Block. Br Heart J. 1975;37(9):984–986.; AlJaroudi WA, Alraies MC, Wazni O et al. Yield and Diagnostic Value of Stress Myocardial Perfusion Imaging in Patients Without Known Coronary Artery Disease Presenting with Syncope. Circ Cardiovasc Imaging. 2013; 6 (3):384–391.; Boran KJ, Oliveros RA, Boucher CA et al. IschemiaAssociated Intraventricular Conduction Disturbances During Exercise Testing as a Predictor of Proximal Left Anterior Descending Coronary Artery Disease. Am J Cardiol. 1983; 51(7):1098–1102.; Durães AR, Passos LCS, Falcon HCDS et al. Bundle Branch Block: Right and Left Prognosis Implications. Interv Cardiol J. 2015;2:1.; Pediatric and Congenital Electrophysiology Society (PACES); Heart Rhythm Society (HRS); American College of Cardiology Foundation (ACCF); American Heart Association (AHA); American Academy of Pediatrics (AAP); Canadian Heart Rhythm Society (CHRS), Cohen MI, Triedman JK, Cannon BC, et al. PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff–Parkinson–White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern: Developed in Partnership Between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the Governing Bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS). Heart Rhythm. 2012;9(6):1006–1024.; Bricker JT, Porter CJ, Garson A Jr et al. Exercise Testing in Children with Wolff–Parkinson–White Syndrome. Am J Cardiol. 1985;55(8):1001–1004.; Perry JC, Giuffre RM, Garson A Jr. Clues to the Electrocardiographic Diagnosis of Subtle Wolff–Parkinson– White Syndrome in Children. J Pediatr. 1990;117(6):871–875.; Daubert C, Ollitrault J, Descaves C et al. Failure of the Exercise Test to Predict the Anterograde Refractory Period of the Accessory Pathway in Wolff Parkinson White Syndrome. Pacing Clin Electrophysiol. 1988;11(8):1130–1138.; Moltedo JM, Iyer RV, Forman H et al. Is Exercise Stress Testing a Cost-Saving Strategy for Risk Assessment of Pediatric Wolff–Parkinson–White Syndrome Patients? Ochsner J. 2006;6(2):64–67.; Zipes D, Libby P. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 11th Edition. Elsevier, 2018:648–669.; Gaita F, Giustetto C, Riccardi R et al. Stress and Pharmacologic Tests as Methods to Identify Patients with Wolff–Parkinson–White Syndrome at Risk of Sudden Death. Am J Cardiol. 1989;64(8):487–490.; Santinelli V, Radinovic A, Manguso F et al. The Natural History of Asymptomatic Ventricular PreExcitation a Long-Term Prospective Follow-Up Study of 184 Asymptomatic Children. J Am Coll Cardiol. 2009; 53(3):275–280.; Bromberg BI, Lindsay BD, Cain ME et al. Impact of Clinical History and Electrophysiologic Characterization of Accessory Pathways on Management Strategies to Reduce Sudden Death Among Children with Wolff–Parkinson– White Syndrome. J Am Coll Cardiol. 1996;27(3):690–695.; Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration with EACTS. Eur Heart J. 2016; 37(38):2893–2962.; Priori SG, Schwartz PJ, Napolitano C et al. Risk Stratifi cation in the Long-QT Syndrome. N Engl J Med. 2003;348(19):1866–1874.; Hekkala AM, Viitasalo M, Väänänen H et al. Abnormal Repolarization Dynamics Revealed in Exercise Test in Long QT Syndrome Mutation Carriers with Normal Resting QT Interval. Europace. 2010;12 (9):1296–1301.; Horner JM, Horner MM, Ackerman MJ. The Diagnostic Utility of Recovery Phase QTc During Treadmill Exercise Stress Testing in the Evaluation of Long QT Syndrome. Heart Rhythm. 2011;8(11):169–1704.; Priori SG, Wilde AA, Horie M et al. HRS/EHRA/ APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes: Document Endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932–1963.; Xu G, Gottschalk BH, Kocabaş U et al. Not All Brugada Electrocardiogram Patterns Are Brugada Syndrome or Brugada Phenocopy. Balkan Med J. 2017;34(6):593.; Amin AS, de Groot EA, Ruijter JM et al. Exerciseinduced ECG Changes in Brugada Syndrome. Circ Arrhythm Electrophysiol. 2009;2(5):531–539.; Makimoto H, Nakagawa E, Takaki H et al. Augmented ST-segment Elevation During Recovery from Exercise Predicts Cardiac Events in Patients with Brugada Syndrome. J Am Coll Cardiol. 2010; 56 (19): 1576–1584.; Rolf S, Bruns HJ, Wichter T et al. The Ajmaline Challenge in Brugada Syndrome: Diagnostic Impact, Safety, and Recommended Protocol. Eur Heart J. 2003; 24(12):1104–1112.; Massin MM. The Role of Exercise Testing in Pediatric Cardiology. Arch Cardiovasc Dis. 2014;107(5): 319–327.; Hayashi M, Denjoy I, Extramiana F et al. Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation. 2009; 119(18):2426–2434.; Karlsson D, Engvall J, Ando AA et al. Exercise Testing for Long-Term Follow-Up in Arrhythmogenic Right Ventricular Cardiomyopathy. J Electrocardiol. 2017;50(2): 176–183.; Jouven X, Zureik M, Desnos M et al. Long-Term Outcome in Asymptomatic Men with Exercise-Induced Premature Ventricular Depolarizations. N Engl J Med. 2000; 343(12):826–833.; Aneq MA, Lindstrӧm L, Fluur C et al. LongTerm Follow-Up in Arrhythmogenic Right Ventricular Cardiomyopathy Using Tissue Doppler Imaging. Scand Cardiovasc J. 2008;42(6):368–374.; Haywood AF, Merner ND, Hodgkinson KA et al. Recurrent Missense Mutations in TMEM43 (ARVD5) Due to Founder Effects Cause Arrhythmogenic Cardiomyopathies in the UK and Canada. Eur Heart J. 2013;34(13):1002–1011.; Zipes DP, Camm AJ, Borggrefe M et al. ACC/AHA/ ESC 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/ American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in Collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(10):e385–484.; Трешкур Т. В., Татаринова А. А., Рыньгач Е. А. и др. «Портрет» желудочковой аритмии у больного ишемической болезнью сердца при холтеровском мониторировании — базовая ступень в выборе тактики ведения. Профилактическая медицина. 2018;6:93–105.; Голицын С. П. Устранение желудочковых аритмий и снижение риска смерти: всегда ли пути в одном направлении? Сердце: журнал для практикующих врачей. 2006;5(1):4–11.; Бокерия Л. А., Ревишвили А. Ш., Неминующий Н. М. Внезапная сердечная смерть. М.: ГЭОТАРМедиа, 2013.c.272.; Шляхто Е. В., Трешкур Т. В., Тулинцева Т. Э. и др. Алгоритм ведения пациентов с желудочковыми аритмиями. Терапевтический архив. 2015;87(5):106–112.; Аронов Д. М., Лупанов В. П. Функциональные пробы в кардиологии. (3-е изд., перераб. и доп.). М.: «МЕДпресс-информ», 2007.c.328.; https://transmed.almazovcentre.ru/jour/article/view/473